Who are Title21 Health Solutions's investors?

Title21 Health Solutions's investors include ARCHIMED Japan.

Title21 Health Solutions

Founded 2001 · 35 employees on LinkedIn · 1 known investors

Find your way into Title21 Health Solutions

157 people in our graph share verified history with the Title21 Health Solutions team — schools, employers, funds. One of them is your warm intro.

Anthony Fariasunlockedknows Tony Pare · together at Title21 Health Solutions (overlapped)

×2knows the team · via Title21 Health Solutions

×4knows the team · via Hemanext

knows the team · via T2 Biosystems

×4knows the team · via ABB

Title21 provides software solutions for cellular therapy and biopharmaceutical manufacturing organizations, offering digital tools for patient coordination, manufacturing workflows, quality management, and regulatory compliance.

Biotech Healthtech Medical Devices SaaS

Founders & leadership

Tony Pare Chief Executive Officer2024–2026Tony Pare held executive roles in healthcare, including Chief Commercial Officer at T2 Biosystems where he led a pivot to SARS-CoV-2 diagnostics, and a position at BioPorto, a publicly traded diagnostics company, where he managed FDA approval for a biomarker assay for acute kidney injury risk assessment. His background spans medical devices, in vitro diagnostics, and healthcare software, with experience in strategic planning, fundraising, and organizational leadership.

Investors · 1

ARCHIMED Japanlisted by ARCHIMED JapanLyon · $10.8M – $1.1B

Frequently asked questions

What does Title21 Health Solutions do?: Title21 provides software solutions for cellular therapy and biopharmaceutical manufacturing organizations, offering digital tools for patient coordination, manufacturing workflows, quality management, and regulatory compliance.
Who are Title21 Health Solutions's investors?: Title21 Health Solutions's investors include ARCHIMED Japan.